BRIDGEWATER, New Jersey, [November 20, 2012] – Valeritas announced today that is has been named "Life Science Company of the Year" by the New Jersey Technology Council (NJTC). The NJTC selected Valeritas as the winner of this award due to the company's targeted mission and clinical focus on the development of technologies that help improve and simplify the lives of people with Type 2 diabetes, as well as the experience of its Executive Management Team in developing and commercializing devices at high volumes. The Bridgewater-based company is known for its leading product, the V-Go™, a wearable device for the delivery of insulin. By developing and commercializing the V-Go, the company seeks to provide a groundbreaking treatment option for patients and address the need for more compliance and adherence in the diabetes therapeutic area.
"Receiving the New Jersey Technology Council Life Science Company of the Year is an honor for Valeritas since it is an affirmation of our efforts as an organization," said Kris Peterson, CEO of Valeritas, Inc. "We are embarking upon our national launch and bringing our product, V-Go, to Type 2 diabetes patients. This award recognizes our innovation and the fact that we will be able to make a difference in the lives of these patients."